Phase Transition for Invariant Measures of the Focusing Schrödinger Equation
Communications in Mathematical Physics · 2026-04 · 407 (4)
DOI: 10.1007/s00220-026-05586-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communications in Mathematical Physics, online erschienen am 24.03.2026. Verfasst von Leonardo Tolomeo und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leverhulme Trust, Horizon 2020 Framework Programme, Royal Society.
Abstract (Originalsprache)
We consider the Gibbs measure for the focusing nonlinear Schrödinger equation on the one-dimensional torus $${\mathbb {T}}$$ T , that was introduced in a seminal paper by Lebowitz et al. (J Stat Phys 50(3):657—687, 1988). We show that in the large torus limit, the measure exhibits a phase transition, depending on the size of the nonlinearity. This phase transition was originally conjectured on the basis of numerical simulation by Lebowitz et al. (J Stat Phys 50(3):657—687, 1988). Its existence is however striking in view of a series of negative results by McKean (Commun Math Phys 168(3):479—491, 1995) and Rider (Commun Pure Appl Math 55(10):1231—1248, 2002).
Förderung
- Leverhulme Trust
- Horizon 2020 Framework Programme
- Royal Society
- Universität Münster
Zitieren
APA
Tolomeo, L., & Weber, H. (2026). Phase Transition for Invariant Measures of the Focusing Schrödinger Equation. Communications in Mathematical Physics, 407(4). https://doi.org/10.1007/s00220-026-05586-5
Vancouver
Tolomeo L, Weber H. Phase Transition for Invariant Measures of the Focusing Schrödinger Equation. Communications in Mathematical Physics. 2026;407(4). doi:10.1007/s00220-026-05586-5
BibTeX
@article{Tolomeo2026,
author = {Tolomeo, Leonardo and Weber, Hendrik},
title = {Phase Transition for Invariant Measures of the Focusing Schrödinger Equation},
journal = {Communications in Mathematical Physics},
year = {2026},
volume = {407},
number = {4},
doi = {10.1007/s00220-026-05586-5}
}
EUVIMED